Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 13Lung Neoplasms 9Carcinoma, Renal Cell 7Rectal Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Esophageal Neoplasms 4Breast Neoplasms, Male 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Kidney Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Brain Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Spinal Cord Neoplasms 2

Interventions

vatalanib 1tanespimycin 1gallium Ga 68 dotatate 1Vorinostat 1Ranibizumab 1PT2385 1Oxygen-15 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × von Hippel-Lindau Disease × Fluorodeoxyglucose F18 × Clear all
NCT00088374 2012-07-27

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡